Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,268 | -47,187 | -24,645 | 5,223 | 2,837 |
| Depreciation Amortization | 184 | 398 | 452 | N/A | N/A |
| Accounts receivable | -35 | -200 | -936 | N/A | N/A |
| Other Working Capital | -672 | 2,300 | -1,090 | -136 | 244 |
| Other Operating Activity | -1,712 | 12,376 | 2,216 | -6,209 | -3,507 |
| Operating Cash Flow | $-10,503 | $-32,313 | $-24,003 | $-1,123 | $-426 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7 | -655 | -451 | N/A | N/A |
| Purchase Sale Intangibles | -67 | -131 | -63 | N/A | N/A |
| Other Investing Activity | -67 | -1,131 | -1,063 | 91 | 11 |
| Investing Cash Flow | $-74 | $-1,786 | $-1,514 | $91 | $11 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 900 | 265 |
| Debt Repayment | -22 | -131 | -4 | N/A | N/A |
| Common Stock Issued | 50 | 94 | 73 | N/A | N/A |
| Other Financing Activity | 7,902 | 13,499 | 7,485 | 0 | 0 |
| Financing Cash Flow | $7,930 | $13,462 | $7,554 | $900 | $265 |
| Beginning Cash Position | 9,664 | 30,301 | 30,301 | 201 | 201 |
| End Cash Position | 7,017 | 9,664 | 12,338 | 69 | 51 |
| Net Cash Flow | $-2,647 | $-20,637 | $-17,963 | $-132 | $-150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,503 | -32,313 | -24,003 | -1,123 | -426 |
| Capital Expenditure | -7 | -655 | -451 | N/A | N/A |
| Free Cash Flow | -10,510 | -32,968 | -24,454 | -1,123 | -426 |